SHINGRIX

This brand name is authorized in Austria, Canada, Croatia, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Spain.

Active ingredients

The drug SHINGRIX contains one active pharmaceutical ingredient (API):

1
UNII COB9FF6I46 - RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN
 

Human varicella zoster immunoglobulin contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against varicella-zoster virus. It is used for prophylaxis against varicella zoster virus (VZV) infection.

 
Read more about Human varicela zoster immunoglobulin

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 SHINGRIX Powder for suspension for injection MPI, EU: SmPC European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
J07BK03 J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BK Varicella zoster vaccines
Discover more medicines within J07BK03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
CA Health Products and Food Branch 02468425
EE Ravimiamet 1767315, 1767326
ES Centro de información online de medicamentos de la AEMPS 1181272001
FI Lääkealan turvallisuus- ja kehittämiskeskus 176947
FR Base de données publique des médicaments 62887096
HK Department of Health Drug Office 66840
IL מִשְׂרַד הַבְּרִיאוּת 9249
IT Agenzia del Farmaco 046337010, 046337022
JP 医薬品医療機器総合機構 631341BE1028
LT Valstybinė vaistų kontrolės tarnyba 1085276, 1085277
NL Z-Index G-Standaard, PRK 202843
NZ Medicines and Medical Devices Safety Authority 20173
PL Rejestru Produktów Leczniczych 100402280

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.